On Nov 01, major Wall Street analysts update their ratings for $Bristol-Myers Squibb (BMY.US)$, with price targets ranging from $36 to $60.
Morgan Stanley analyst Terence Flynn maintains with a sell rating, and adjusts the target price from $37 to $36.
BofA Securities analyst Charlie CY Yang initiates coverage with a hold rating, and sets the target price at $60.
Barclays analyst Carter Gould maintains with a sell rating, and maintains the target price at $43.
TD Cowen analyst Steve Scala maintains with a hold rating, and maintains the target price at $59.
BMO Capital analyst Evan Seigerman maintains with a hold rating, and maintains the target price at $53.
Furthermore, according to the comprehensive report, the opinions of $Bristol-Myers Squibb (BMY.US)$'s main analysts recently are as follows:
Bristol Myers delivered satisfactory Q3 results, surpassing expectations in both revenues and EPS, largely due to the performance of the off-patent Revlimid. An improved outlook from the company's growth portfolio has resulted in a more optimistic perspective on the stock, with raised revenue and EPS forecasts for 2024. Despite this, a cautious stance is maintained due to persisting uncertainties regarding the longer-term earnings potential.
Here are the latest investment ratings and price targets for $Bristol-Myers Squibb (BMY.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
